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Abstract Notch is an intercellular signaling pathway
related mainly to sprouting neo-angiogenesis. The objec-
tive of our study was to evaluate the angiogenic mecha-
nisms involved in the vascular augmentation (sprouting/
intussusception) after Notch inhibition within perfused
vascular beds using the chick area vasculosa and MxCre-
Notch1(lox/lox) mice. In vivo monitoring combined with
morphological investigations demonstrated that inhibition
of Notch signaling within perfused vascular beds remark-
ably induced intussusceptive angiogenesis (IA) with
resultant dense immature capillary plexuses. The latter
were characterized by 40 % increase in vascular density,
pericyte detachment, enhanced vessel permeability, as well
as recruitment and extravasation of mononuclear cells into
the incipient transluminal pillars (quintessence of IA).
Combination of Notch inhibition with injection of bone
marrow-derived mononuclear cells dramatically enhanced
IA with 80 % increase in vascular density and pillar
number augmentation by 420 %. Additionally, there was
down-regulation of ephrinB2 mRNA levels consequent to
Notch inhibition. Inhibition of ephrinB2 or EphB4 signal-
ing induced some pericyte detachment and resulted in up-
regulation of VEGFRs but with neither an angiogenic
response nor recruitment of mononuclear cells. Notably,
Tie-2 receptor was down-regulated, and the chemotactic
factors SDF-1/CXCR4 were up-regulated only due to the
Notch inhibition. Disruption of Notch signaling at the
fronts of developing vessels generally results in massive
sprouting. On the contrary, in the already existing vascular
beds, down-regulation of Notch signaling triggered rapid
augmentation of the vasculature predominantly by IA.
Notch inhibition disturbed vessel stability and led to peri-
cyte detachment followed by extravasation of mononuclear
cells. The mononuclear cells contributed to formation of
transluminal pillars with sustained IA resulting in a dense
vascular plexus without concomitant vascular remodeling
and maturation.
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Introduction
Angiogenesis is essential for normal embryonic develop-
ment and plays a key role in pathological conditions
related to tumor growth and ischemic cardiovascular dis-
eases. Angiogenesis involves the formation of new blood
vessels from a preexisting vascular plexus, and based on
morphological characteristics, two distinct processes have
been identified: sprouting angiogenesis and intussuscep-
tive angiogenesis (IA) [1–3]. Sprouting angiogenesis has
been well described in the recent literature and involves
tip/stalk cell differentiation in the sprout and is tightly
controlled by the Notch/Dll4 signaling pathway [4].
Intussusceptive angiogenesis is a specific mode of blood
vessel formation by which instead of extraluminally,
endothelial cells form intraluminal ‘‘sprout like’’ protru-
sions resulting in the formation of transluminal endothe-
lial pillars. Successive reshaping and fusion of such pillars
‘‘splits’’ the preexisting segment in two parts, thus
resulting in the formation of an additional vessel segment.
This results in formation of supplying and draining ves-
sels, pruning of arteries and veins, and finally remodeling
of the primitive capillary plexuses. IA is a step process
involving intussusceptive microvascular growth, intussus-
ceptive arborization, and intussusceptive remodeling [2, 3,
5, 6]. The processes lead to formation of hierarchically
organized and mature vascular networks. Compared to
sprouting angiogenesis, intussusception is relatively fast,
thus allowing swift vascular adaptation in compromised
conditions. In liver regeneration models and in post-
pneumonectomy alveolar angiogenesis, intussusception
has been identified as the predominant mode of growth,
and also in extraembryonic vasculatures including the
vitelline circulation, intussusception appears to prevail
over sprouting [7–9]. Surprisingly, the cellular and
molecular regulation of intussusception is less well
known, but recent evidence suggests that it might involve
components regulated by blood flow and Notch signaling
[6, 7]. Here, we provide evidence showing that Notch
regulates intussusception involving interaction with cir-
culating mononuclear cells in developing vascular
networks.
The Notch signaling pathway is evolutionary conserved
and plays an important role in cell fate specification and
differentiation. The Notch pathway is activated after the
Notch receptor binds one of its ligands from Delta and
Serrate families, which are expressed by neighboring cells
[10]. Notch receptors are single Type I transmembrane
proteins located on the cell surface, which interact with
ligands expressed on the adjacent cells. It leads to splitting
of the receptor by TACE and c-secretase and subsequent
translocation of its intracellular portion (NICD) into the
nucleus. The subsequent interaction with RBP-Jk/CBF-1
protein complex results in expression of genes normally
silent in absence of Notch signal such as basic helix-loop-
helix genes Hes 1, 5, 7 and Hesr/Hey 1, 2, L. In mice, loss
and gain of function studies for Notch receptors and Notch
ligands including Dll4/Jag1 and Dll1 has shown that Notch
signaling is essential for normal arterial-venous differen-
tiation and remodeling and for angiogenic sprouting [11–
14]. In angiogenic sprouts, Dll4/Notch signaling acts as a
negative regulator of endothelial tip cell differentiation.
Dll4 expressed by endothelial tip cells, activates Notch
receptors in stalk cells, resulting in the suppression of
VEGFR2, and up-regulation of VEGFR1, a feedback
mechanism essential for maintaining adequate tip/stalk cell
balance. Gerhardt et al. demonstrated that during sprouting
angiogenesis, endothelial cells compete for the leading tip
position, and it is dependent not on the absolute but on the
relative VEGFR levels between cells. The cells expressing
less VEGFR1 or more VEGFR2 have high probability to be
found at the tip position, and VEGFR level-mediated
competition is strictly Notch dependent [4]. In addition to
negative effects on sprouting, Notch signaling has also
been shown to have effects on stabilization of vasculature
and vessel remodeling [15–19].
Among the complex angiogenic processes regulated by
Notch signaling, interactions between endothelial cells and
mural cells (pericytes and vascular smooth muscle cells)
have recently come into focus as central processes in
vascular formation, stabilization, remodeling, and function
[20–22]. Up-regulation of Notch signaling in mural cells
induces expression of smooth muscle cell (SMC) marker
genes, contributes to vessel stabilization and finally to
formation of robust and mature vascular networks [23].
EphrinB2/EphB4 signaling is essential for managing the
adhesion/repulsion processes, intercellular contacts, and
cell migration as well [24, 25]. Functional and molecular
analyses show that ephrinB2 is a direct target of Notch
signaling [26–28], and it is plausible that they both con-
tribute to vessel maturation and maintenance.
Recently, several groups have found that blockade of
Notch signaling leads to disorganized and unproductive
endothelial growth, which results in tumor regression [29–
31]. Similarly, DLL4 inhibition causes formation of a
disorganized capillary network in ischemic muscles [32].
Notch inhibition induces deregulated endothelial sprouting
and proliferation, independently of VEGFR2, in mouse
retina as well [33]. Notch signaling has been mostly related
to sprouting neo-angiogenesis. It is obvious that in non-
vascularized tissues, especially in non-perfused fronts of
developing vessels, for example, in vitro experiments, and
in expanding retinal vessels, inhibition of Notch results in
extensive formation of capillary sprouts.
Surprisingly, within liver vasculature, it has been shown
that Notch1 knockout (KO) mice develop portal
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hypertension and nodular regenerative hyperplasia through
sinusoidal remodeling by intussusceptive angiogenesis [7].
Evaluation of the embryonic vascular pattern in the lit-
erature indicates that intussusceptive angiogenesis is most
likely ‘‘locked’’ in the ‘‘on’’ position (intussusceptive
microvascular growth) after Notch inhibition resulting in
repetitive pillar formation with no subsequent remodeling
or maturation.
In this study, using the chick area vasculosa and a mouse
model of Notch inhibition, we have demonstrated that in
already existing vascular beds, disruption of Notch sig-
naling triggers rapid augmentation of the vasculature pre-
dominantly by intussusceptive angiogenesis. The process is
characterized by pericyte detachment and extravasation of
mononuclear cells. The latter cells contribute to formation
of transluminal pillars. The sustained IA results in a very
dense vascular plexus but without the usual concomitant
vascular remodeling or maturation. We have studied
potential molecular mediators of Notch signaling as well.
Methods
Animals
Fertilized white leghorn eggs were obtained from com-
mercial breeders (Fribourg, Switzerland). The eggs were
incubated in-shell for 3 days at 37 C in humidified (65 %)
atmosphere, containing 1–2 % CO2. The eggs were opened
on day 3 and further incubated at the same conditions using
shell-free method [2] in petri dishes (Corning Incorporated,
Corning, NY, USA). The samples were divided into a
control group (Co) and groups of inhibition (I). There were
at least six chicken embryos investigated in each group.
MxCre Notch1(lox/lox) mice on a C57Bl/6 background
carry the Cre-recombinase under the murine Mx1 pro-
moter. To induce recombination, 300 lg of polyinosinic-
polycytidylic acid (pIpC) (InvivoGen, San Diego, CA,
USA) was injected intraperitoneally in 4-week-old mice at
days 0, 3, and 6, resulting in efficient deletion of Notch1 in
the liver already after 1 day. Notch1 deletion was consis-
tent in liver sinusoidal endothelial cells (LSECs) and
hepatocytes during the whole observation period.
Reagents
The c-secretase inhibitor 1 (GSI-1) (Calbiochem, Swit-
zerland) is a potent and selective inhibitor of the c-
secretase complex. The drug with a concentration of
10 lg/ll was dissolved in phosphate-buffered saline
(PBS), and 2 lg of the test solution was applied per
quadrant (corresponded to a dose of 80 mg/kg). Control
samples of the area vasculosa from the same time points
and with the same size as GSI-treated ones were treated
with equal volumes of PBS. To block EphB4 forward
signaling, we used NVP-BHG712, a novel small molec-
ular weight inhibitor designed to block EphB4 phos-
phorylation (Novartis Institutes for BioMedical Research,
Basel, Switzerland). Successful blocking was previously
determined by evaluation of EphB4 phosphorylation, and
the effective dose was 50–100 mg/kg [34]. Bioactivity of
ephrinB2 was neutralized with anti-ephrinB2 antibody
(Neuromics, Edina, MN 55439), and presence of the
protein was detected by immunohistochemistry. After
testing different doses, the successful neutralization was
attained at the dose of 40 mg/kg.
RNA isolation and real-time reverse transcription PCR
Total RNA was extracted from Notch1 KO mouse and
control livers and from the treated lower right quadrant of the
area vasculosa, after inhibitions and also from non-inhibited
samples, by using RNeasy Mini kit (Qiagen, Basel, Swit-
zerland). The RNA concentrations were determined spec-
trophotometrically. cDNA was synthesized by reverse
transcription (1 h at 37 C) using 2 lg of total RNA, 1 lg of
the oligo(dT) primers, and 4 U of ImPromp-II reverse
transcriptase (Promega, Wallisellen, Switzerland). cDNA
concentrations were then determined using the PicoGreen
dsDNA quantification reagent (Invitrogen, Basel, Switzer-
land). The following primer/probe kits were purchased from
Qiagen: 1) Chicken QuantiTest Primer Assay DLL4 (QT0065
6936), Notch2 (QT01504986), Hes5 (QT00630406), ephrinB2
(QT00591794), KDR2 (QT01140244), PCNA (QT00588952),
and caspase-3 (QT00588952), VEGFR1 (Flt1) (QT00595987),
SDF-1 (CXCL12) (QT01139026), CXCR4 (QT00590128),
Tie-2 (TEK) (QT00685629); 2) Mouse QuantiTest Primer
Assay Mm_Cxcl12(SDF-1)_1_SG (QT00161112), and Mm_
Cxcr4_1_SG (QT00249305). Quantitative PCR was performed
using real-time PCR (R Corbett Research RG-6000). The fold-
change expression levels of cDNA were determined from the
DCt values obtained as compared to DCt values of control
samples. In our experiment, we used GAPDH (QT00588973)
and ACTB (QT00600614) as housekeeping genes.
Morphometry
Evaluation of vascular parameters was accomplished with
Tem Imaging Platform (iTEM) software. Micrographs
were obtained from normally developing area vasculosa in
order to acquire baseline data and a normal growth curve.
From the experimental group, micrographs were taken
from inhibited samples at time points 6, 12, and 24 h. The
arterial tree of the lower right quadrant was traced in a
user-driven way. Subsequently, the arterial tree thus
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obtained was analyzed with the iTEM software to deter-
mine vascular length and number of branching points.
The visualization of microvasculature was done by
injection of 50 ll of 10 % FITC-Dextran 2000 kDa (FD-
2000S, Sigma-Aldrich, Germany) in 0.9 % NaCl solution,
prior to inspection in an epifluorescence microscope
(Polyvar-Reichert, Glattbrugg, Switzerland) equipped with
a Canon 5D Mark II camera for both video recording and
taking still images. The still images and video sequences of
at least 4 fields of view were taken per application site for
further quantitative evaluation. Microvascular density and
pillar numbers were evaluated using analySIS Software 5.0
(Soft Imaging System, Muenster, Germany).
Transmission electron microscopy
The samples obtained from the area vasculosa and PBS
controls harvested at different time points were immersion-
fixed in 2.5 % glutaraldehyde solution buffered with
0.03 M potassium phosphate (pH 7.4, 370 mOsm). The
livers of Notch1 KO and wild-type mice were perfused
with fixative [2.5 % glutaraldehyde in 0.1 mol/L cacodyl-
ate buffer (pH 7.4, 350 mOsm)]. Then, the liver was
excised, cut into small pieces, and immersed in the same
fixative.
All samples were then postfixed in 1 % OsO4 (buffered
with 0.1 M sodium cacodylate—pH 7.4, 370 mOsm),
dehydrated in ascending concentrations of ethanol, and
embedded in epoxy resin. For light microscopy, 1-lm-thick
sections were prepared using glass knives and stained with
toluidine blue. For transmission electron microscopy,
80–90-nm-thick sections were prepared and mounted on
copper grids coated with Formvar (polyvinyl formal;
Fluka, Buchs, Switzerland). They were stained with lead
citrate and uranyl acetate prior to viewing in a Philips EM
400 electron microscope.
Vascular casting
Vascular casts were prepared as previously described [35].
Briefly, CAM vasculature/the vasculature of the murine
liver were perfused with a freshly prepared solution of
Mercox (Vilene Company, Japan) containing 0.1 mL of
accelerator per 5 mL of resin. One hour after perfusion, the
CAM were transferred to 7.5 % potassium hydroxide for
digestion of tissue, which was effected over a course of
2–3 weeks. After washing, the casts were dehydrated in
ethanol and dried in a vacuum desiccator. The samples
were then sputtered with gold to a thickness of 10 nm and
examined in a Philips XL-30 SFEG scanning electron
microscope.
Three-dimensional reconstruction from serial semithin
sections
Images of serial semithin sections showing sites of interest
were taken. The 3D stack of images obtained was aligned
and further processed using Imaris Software (Bitplane
Scientific Software, Zurich, Switzerland). The 3D surface
at the outer border of the vascular lumen was generated
(red), and the volume corresponding to the cells invading
the pillar was presented in green.
Western blot analysis
Treated and control samples of the area vasculosa at dif-
ferent time points were pooled (at least 5 embryos in each
pool), collected, and homogenized in lysis buffer contain-
ing protease inhibitors (Roche, Switzerland). Protein con-
centration was determined, and SDS-PAGE was performed
with 30 lg of extracted proteins. Samples were run on a gel
and transferred onto polyvinylidene fluoride membranes.
Membranes were blocked in blocking buffer (5 % nonfat
dry milk in TBS, 0.1 % Tween 20) and incubated overnight
at 4 C with primary anti-aSMA antibody.
In vivo permeability assay
Hoechst dye (Sigma-Aldrich, Buchs, Switzerland), 0.4 %
diluted in DPBS, was intravenously injected in chick area
vasculosa. After 20 min, FITC-conjugated lectin (Sigma-
Aldrich, L9381; 10 lg in 10 ll volume per treated area)
was intravenously injected to visualize endothelial cells,
and after 10 min of circulation, the treated area vasculosa
was removed and prepared for cryosectioning. Sections
were air-dried overnight, acetone-fixed, embedded in
Mowiol, and immediately analyzed by fluorescence
microscopy (Leica MZ16FA microscope connected to a
Leica DFC320 Digital Camera with the ThumbsPlus 79
software).
Mononuclear cell counting
The serial sections were viewed and images captured at
magnification 409 using a light microscope (Leica, Leitz
DM), equipped with Leica DFC480 camera. At least 10
images were taken per sample for further quantitative
evaluation, and at least 10 samples for each application
were evaluated. The total number of adherent/extravasated
mononuclear cells per vessel circumference was assessed
using analySIS Software 5.0 (Soft Imaging System,
Muenster, Germany) by means of user-driven skeleton-
ization of the vascular circumference.
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Bone marrow mononuclear cells isolation and labeling
To isolate bone marrow mononuclear cells, 4–6-week-old
male BALB/c mice (BALB/cByJ, Charles River Labora-
tories, France) were sacrificed and their femur and tibia
collected in DMEM (Gibco) supplemented with 10 % FBS
(fetal bovine serum, Sigma-Aldrich, Germany). Bone
marrow was flushed-off using PBS with 2 % FBS and
collected in a tube with 2 mM EDTA/PBS. The solution
was then diluted with 109 volume RPMI1640 containing
0.02 % collagenase B and 100 U/ml DNase and agitated
gently at room temperature for 45 min. The cells were
passed through 30 lm nylon mesh, centrifuged, and
resuspended in PBS. The cell suspension was gently and
slowly added onto a tube containing the same volume of
Histopaque-1077 (Sigma-Aldrich, Cat. 10771). After
30-min centrifugation, the white cellular ring floating over
the Ficoll phase (mononuclear cells) was collected and
transferred into a new tube, filled with 19 PBS, and cen-
trifuged to wash. The cells were warmed up (in DMEM)
for 20 min at 37 C. TAMRA stock solution (TAMRA
from Sigma Cat. No 1171, solved in N,N-dimethylform-
amide from Sigma Cat. No 539465) was added to the cells
to get a concentration of 200 lmol/l. Thereafter, the cells
were incubated with TAMRA for 20 min., washed twice,
resuspended in an appropriate amount of medium (in order
to have 2–4 9 105 cells for each injection), and mixed with
15 % FITC in a ratio 3:1.
Statistical analysis
Probability associated with a Student’s paired t test, with a
two-tailed distribution, was considered in a given p value
for each comparison.
Results
Expression changes in genes related to Notch function
Using the chick area vasculosa (Hamburger and Hamilton
stages HH23-HH30), we performed expression analysis for
Notch2, DLL4, and ephrinB2 in normal development
(Fig. 1a, n = 10 for each time point and condition).
Starting from the embryonic day 4 (E4, time point 0), we
detected a peak of Notch2 expression 6 h later and applied
the inhibitor before the peak time. To verify successful
blocking of Notch signaling by differential doses and types
Fig. 1 Expression levels of genes related to Notch function in the
chick area vasculosa after Notch inhibition by GSI. a Time course of
DLL4, Notch2, and ephrinB2 expression during normal development
of the chick area vasculosa. b A significant decrease in the expression
levels of DLL4, Notch2, ephrinB2, and Hes5 is achieved after three
applications of GSI (2 lg at 0, 6 and 12 h). c Up-regulation of
classical angiogenic factors VEGFR1, VEGFR2, and bFGF under GSI
treatment. d Cell turnover estimated by expression levels of caspase-3
and PCNA after Notch inhibition
Angiogenesis (2013) 16:921–937 925
123
926 Angiogenesis (2013) 16:921–937
123
of application of the c-secretase inhibitor (GSI), we mon-
itored expression levels of Notch2, DLL4, and the Notch
target Hes5 in parallel with controls. The most efficient
blocking was reached by doses of 2 lg of GSI per lower
right quadrant of the area vasculosa (corresponding to
40–80 mg/kg). Chronic blockade was achieved after dou-
ble and triple application of GSI. The mRNA levels of
Hes5, DLL4, and ephrinB2 were significantly lower in all
inhibited samples than in the controls (Fig. 1b).
Looking for potential molecular targets of Notch inhi-
bition, we investigated the expression changes in some of
the classical factors of apoptosis, proliferation, and angio-
genesis. VEGFR2 and especially VEGFR1 were up-regu-
lated after Notch inhibition, and increase in expression
levels of bFGF was detected as well (Fig. 1c). The
expression of apoptosis marker caspase-3 consistently
decreased during the time course of GSI application
(Fig. 1d). The proliferation marker PCNA slightly
increased its expression levels (Fig. 1d).
Notch inhibition results in pericyte detachment,
extravasation of mononuclear cells and formation
of transvascular tissue pillars
The significant decrease in ephrinB2 mRNA levels after
Notch inhibition prompted us to investigate the angiogenic
effects upon blockade of the forward and reverse ephrinB2/
EphB4 signaling. The absolute surface area of the treated
lower right quadrant of the area vasculosa was consider-
ably reduced after GSI application in comparison with the
controls (by 54 %) and with ephrinB2 and EphB4 inhibi-
tions (Fig. 2a). Morphological evaluation of semithin sec-
tions at higher magnification revealed disrupted vascular
walls after GSI treatment (Fig. 2b). In all samples treated
with GSI, progressive pericyte detachment from
endothelial cells was observed in the first few hours, so that
after 6 h, large gaps between endothelial cells and peri-
cytes were documented. With time, the gaps appeared
larger, and by 12 h, the pericytes retracted and reshaped to
stellate like cells, and no longer covered the endothelia.
Concomitantly, the first mononuclear cell extravasation
occurred. At 24 h, the vascular wall structure appeared
disorganized, and the morphology was defined by partially
disrupted endothelia with retracted pericytes and a multi-
tude of extravasating mononuclear cells passing through
the endothelial gaps (Fig. 2b).
Slight disturbance of the contacts between pericytes and
endothelia was observed also after inhibition of ephrinB2
and EphB4 (data not shown), but to a much lesser extent
compared to the drastic effects occurring after GSI treat-
ment. The resultant morphological disturbance was related
to the observed protein expression levels. Western blotting
for aSMA revealed around 50 % decreases in this pericyte
marker after Notch inhibition and about 25 % reduction
after ephrinB2 and EphB4 inhibition (Fig. 2c). Addition-
ally, there was a two-fold Tie-2 down-regulation after
Notch inhibition. Tie-2 is a marker associated with vessel
stabilization, but was only slightly down-regulated after
EphB4 inhibition and up-regulated after ephrinB2 inhibi-
tion (Fig. 2c).
The vessel instability resulting from disturbed pericyte
alignment prompted us to investigate vessel permeability.
Using lectin/Hoechst staining as an in vivo permeability
assay (Supplementary Figure 1), we observed much higher
permeability after Notch inhibition, which was in accor-
dance with expression levels of aSMA protein and Tie-2
mRNA.
Morphological evaluation by light and transmission
electron microscopy revealed extravasation of mononu-
clear cells already by 6 h after Notch inhibition (Fig. 3a, b).
Such cells participated in subsequent steps of extrava-
sation (attachment to the endothelium, para- or intracel-
lular passage through the endothelium, invasion of the
basement membrane followed by perivascular accumu-
lation). The extravasated cells phenotypically resembled
stem cell-like cells [41]. Quantitative analyses 24 h after
Notch inhibition demonstrated 6 times more extravasated
mononuclear cells as compared to controls and 3–4 times
more as compared to ephrinB2 and EphB4 inhibition
(Fig. 3a).
To follow and document the fate of the extravasating
mononuclear cells, 3D reconstruction of vessels from GSI-
treated and control samples was undertaken (Fig. 3c). This
was based on sections obtained from regions with pillars
initially identified under video microscopy (see also
Fig. 5). TEM revealed a high number of mononuclear cells
attached to the endothelium and later in the vicinity of
pillars, stabilizing the pillar core from the both sites,
Fig. 2 Disturbed vessel maturation after inhibition of the Notch
signaling. a Overview of the lower right quadrant of the area
vasculosa 24 h after different treatments. Absolute surface area of the
treated quadrant decreased after all inhibitions but is most noticeable
after Notch inhibition (p \ 0.04, n = 12). b Semithin sections
showing disrupted vascular wall integrity after Notch inhibition.
Pericytes (black arrowheads) cover and closely adhere to the
endothelial cells (black arrows) in the controls (PBS). GSI treatment
caused detachment of the pericytes at 6 h and gap formation between
them and the endothelium (asterisks). Non-detached pericytes are
indicated by white arrowheads. By time point 12 h, the gaps appear
larger; the pericytes retract and become star-shaped. The first
mononuclear cells (white arrows) are detectable in the periendothelial
space. By time point 24 h, the vascular wall structure appears
disorganized with very thin and partially disrupted endothelium. The
endothelial gaps are used as an exit for the extravasating mononuclear
cells. c Expression of Tie-2 receptor and SMA protein levels after
different treatments
b
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plausibly indicating their participation in pillar formation
(Fig. 3d). A closer view revealed the presence of mono-
nuclear cells into the pillar core surrounded by collagen
fibers (Fig. 3d). The collagen deposition in the pillar core is
quite an early event and seems to be crucial for the
mechanical stabilization and resistance to flow.
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Induction of intussusceptive microvascular growth
(pillar formation) after Notch inhibition
The effects of Notch versus EphB4 and ephrinB2 inhibi-
tions on microvasculature were further evaluated by FITC-
dextran injection in the area vasculosa (Fig. 4a). Notch
inhibition resulted in very dense capillary networks but
without the classical standard vascular hierarchy. Typical
features of intussusceptive microvascular growth, i.e.,
transluminal tissue pillars were represented by dark dots in
the green perfused vessels (correspond to the red pillar in
Fig. 3c). Figure 4b shows augmentation of microvascular
area density. Inhibition of Notch signaling led to increased
microvascular density by 37.5 % as compared to control
(Fig. 4b). More than three-fold increase in the number of
nascent pillars with diameter less than 2.5 lm indicated
that the preferred angiogenic growth mechanism was
intussusception (Fig. 4c).
Vascular casts from the chick area vasculosa (Fig. 5a)
and MxCre Notch1(lox/lox) mice (Fig. 5b) indicated pro-
foundly enhanced IA characterized by pillar formation,
demonstrated in the cast by tiny holes (correspond to the
red pillar in Fig. 3c). This phenomenon confirms the
hypothesis that inhibition of Notch signaling induces IA in
birds and mammals.
Molecular alterations after blocking of forward
and reverse ephrinB2/EphB4 signaling compared
to Notch inhibition
The classical proangiogenic factor VEGFA and its main
receptors VEGFR2 and VEGFR1 after application of all
inhibitors (Fig. 6a) were also examined. Interestingly,
VEGFR1 was markedly up-regulated in all treated samples
compared to controls with the highest fold-change
expression especially after inhibition of ephrinB2 and its
receptor EphB4. VEGFR2 was also up-regulated after
these two inhibitors but to a lower extent. On the other
hand, VEGFA did not show significant changes, following
treatment with any of the inhibitors (Fig. 6a).
The stroma-derived factor-1 (SDF-1) and its receptor
CXCR4 play a crucial role in the homing of bone marrow-
derived mononuclear cells and their migration. Interest-
ingly, GSI treatment led to an increase in SDF-1 levels by
1.8-fold and CXCR4 expression by 1.5-fold in the area
vasculosa compared to controls. In contrast, treatment with
the EphB4 inhibitor led to down-regulation of SDF-1 by
2.5-fold and of CXCR4 by three-fold. After ephrinB2
inhibition, there was almost no change in the transcription
levels of these genes (1.1- and 0.9-fold-change expression,
respectively) (Fig. 6b).
Additionally, expression analysis for SDF-1 and
CXCR4 mRNA levels done in liver samples from MxCre
Notch1(lox/lox) mice recorded an increase of 38 and 20 %
for SDF-1 and CXCR4, respectively (Fig. 6b).
Increased intussusception in GSI-treated samples
after injection of bone marrow-derived mononuclear
cells
To test the role of bone marrow cells in the process of
intussusception, we isolated bone marrow mononuclear
cells (BMCs) from E14 chicken embryos and/or 4-week-
old mice, labeled them with a fluorescent cell tracker
(TAMRA), and injected them into the inhibited and control
samples 3 h prior to time point 24 h at which time the
samples were visualized by FITC injection (Fig. 7). We
observed much more recruitment and extravasation of the
labeled BMCs in inhibited samples (Fig. 7b, c) as com-
pared to the controls (Fig. 7a).
In addition, 3–4 h after BMCs injection, we observed a
significant induction of intussusception in the GSI-treated area
as we detected high increase in the pillar number (4.2-fold) in
inhibited samples as compared to controls (Fig. 8a–c).
The GSI samples with bone marrow injection showed
the highest increase in pillar number (63 %) as compared
to GSI samples alone (Fig. 8c). Microvascular density
was higher by 80 % in GSI samples compared to controls
after bone marrow injection, and it increased by 30 % in
GSI samples after bone marrow injection compared to
GSI samples alone (Fig. 8c). The effect was local at the
site of application of GSI, as is evident from the images,
showing treated and contralateral side of the same embryo
(Fig. 8a, b).
bFig. 3 Extravasation of mononuclear cells after pericyte detach-
ment—contribution to pillar formation. a Different stages of mono-
nuclear cell extravasation 6 h after GSI treatment of area vasculosa:
attachment to the endothelium (1 and 2), para- or intracellular passage
through the endothelium with invasion of the basement membrane
(3). The number of extravasated mononuclear cells after 24 h was
about 6 times higher in Notch-inhibited samples as compared to
controls (p \ 0.01, n = 12) and 3–4 times more as compared to
ephrinB2 and EphB4 inhibition. b Transmission electron micrographs
documented the significantly enlarged periendothelial space (aster-
isks) bounded by the detached pericytes (Pr) and their protrusions
(arrowheads). Extravasating mononuclear cell (Mo) passing through
the endothelial gap indicated by arrows. Right micrograph is a part of
the left at a higher magnification. c Pillar reconstruction (3D) of serial
semithin sections from GSI-treated area vasculosa (most important
sections demonstrated below) revealing the extravasated mononuclear
cells (green) in the vicinity of pillars; the vascular wall is indicated in
red. d Ultrathin sections revealed a multitude of mononuclear cells
attached to the endothelium (asterisks) and two cells (arrowheads)
from both sides of the pillar as demonstrated in reconstructed images
(c in green). They sent cellular protrusions (double arrows) in the
vicinity of the pillar and are most likely responsible for the collagen
deposition (open arrows) which contributes to additional stabilization
of the pillar and finally resistance to flow. Middle and right
micrographs are parts of the left one at a higher magnification
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In contrast to inhibited samples, pillars were only increased
by 25 % in control samples after bone marrow injection as
compared to control samples without bone marrow injection.
No difference was observed in microvascular density of
control samples after bone marrow injection compared to
control samples without bone marrow injection (Fig. 8c).
Discussion
Using a genetic approach in mice substantiated by phar-
macological studies in developing vascular networks in
chicken embryos, we show that Notch is critical for
intussusceptive angiogenesis. Within already existing vas-
cular beds (chick area vasculosa and MxCre Notch1(lox/
lox) mice), we demonstrated considerable changes in vas-
cular morphogenesis, resulting in massive induction of
intussusception after Notch depletion. The pericytes in both
models were widely detached from endothelium, which
corresponded to down-regulation of Tie-2 receptor and
reduced protein level of aSMA. The vessel surface was
rich in tissue pillars, the hallmarks of intussusceptive
angiogenesis. The latter led to increased microvascular
density by about 40 % compared to controls; at the same
time, the surface area of chick area vasculosa was smaller
by about 50 % in comparison with the controls. We
observed occasionally sprouting vessels in the model. To
our knowledge, this is the first report that within already
existing vascular beds, inhibition of Notch signaling
induces neo-angiogenesis by intussusception and not by
sprouting.
In a recently published study [36], a novel therapeutic
antibody against DLL4 promoted vessel formation result-
ing in a threefold induction in vessel number. This was
associated with a concomitant reduction in the percentage
of smooth muscle actin (SMA)-positive mural cells. The
observed phenotype and the 2D appearance of the blood
vessels closely resemble our data in both the chicken and
the mouse model. Notch inhibition during developmental
angiogenesis, in skeletal muscle and in tumor models
caused similar phenotypes, revealing increased vascular
density and increased vascular leakage [30–32, 37, 38].
The authors in the latter studies described the resultant
vascular pattern as ‘‘abnormal vessels’’ or ‘‘excessive,
nonproductive angiogenesis.’’ Blocking Notch signaling,
they focused mainly on the front of sprouting invasion,
which represents developing, non-formed vasculature.
Despite the observed significant angiogenic activity under
Notch inhibition, the authors mentioned here above nicely
documented reduced mural cell coverage. Endothelial
protrusions in the vessel lumen and intraluminal vessel
occlusions were positive for endothelial markers [38], but
the authors failed to attribute this effect to the induced
intussusceptive angiogenesis. Careful look at the vascular
pattern behind the invading sprouting vessels demonstrated
that in already formed vascular bed, Notch inhibition led to
IA, which is a complementary mechanism of angiogenesis.
The findings described are characteristic features of intus-
susceptive microvascular growth, which we have docu-
mented in the results section by in vivo observation, on
semithin serial sections, and in vascular casts.
Al Haj et al. reported formation of a disorganized,
poorly-perfused capillary network with leukocyte infiltra-
tion and up-regulation of chemo attractant in skeletal
muscle after inhibition of endogenous Dll4 by Ad-sDll4.
The documented vascular pattern represented a dense
capillary plexus expanding by IA. It seems that due to lack
of in vivo follow-up, the authors hypothesize that the loops
(actually pillars, i.e., IA) were sprout connections [32].
Blocking of Notch signaling in mouse retina also led to
significant increase in vascular density [33, 39] with
deregulated endothelial growth but without any increase in
VEGFR2 levels, the main marker for sprouting [33]. Our
previous investigation using VEGF inhibitors in mouse
tumor model and kidney regeneration after Thy1 nephritis
indicated that IA occurs in a VEGF independent manner
and that the tumor could escape anti-VEGF therapy by
switch from sprouting to intussusceptive angiogenesis [40,
41].
Notably, in addition, we revealed extensive extravasa-
tion of mononuclear cells, following GSI treatment, and
their participation in the formation of tissue pillars was
evidently demonstrated. Here, we have revealed that inhi-
bition of Notch signaling disturbs vessel integrity and leads
to increased vessel permeability and recruitment of
mononuclear cells, which extravasate and accumulate in
perivascular spaces. TEM images revealed that extrava-
sated cells were morphologically similar to stem cell-like
cells isolated from murine bone marrow [42]. Thereby, we
isolated BMCs from chicken and mice and tested their
effect in the area vasculosa treated with GSI and PBS. We
observed a major effect of the stimulation of intussuscep-
tion with increase in microvascular area density in Notch-
inhibited samples by 80 % compared to controls and aug-
mentation of pillar number by 420 %. It has been shown
Fig. 4 Inhibition of Notch signaling dramatically induces intussus-
ceptive microvascular growth. a The vasculature of chick area
vasculosa 24 h after different inhibitory treatments (application in the
left upper corner) visualized by FITC-dextran injection. Notch
inhibition represented by different magnifications demonstrated very
dense capillary meshwork. Arrows indicate small transluminal tissue
pillars represented as dark spots, which are reminiscent of intussus-
ceptive angiogenic growth mode. Please see Fig. 8b as comparison to
the PBS control treatment at same magnification. b Microvascular
area density increases significantly after Notch inhibition (*p \ 0.06,
n = 12). c Pillar density estimation demonstrated dramatic augmen-
tation primarily after Notch suppression (*p \ 0.07, n = 12)
b
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that treatment of chicken embryos with donor chicken bone
marrow cells led to high vessel density after irradiation
[43]. Over the last several years, it has been demonstrated
that various bone marrow-derived myeloid cells exert
proangiogenic activity and contribute to different aspects
of angiogenesis [44, 45]. Notch inhibition was connected to
inflammatory angiogenesis in situations such as choroidal
neovascularization [46]. Here, we show for the first time
Fig. 5 Recruitment of mononuclear cells contributes to pillar
formation, i.e., to induction of IA. a Vascular cast from control area
vasculosa revealed standard large vascular loops (asterisks) with
occasional pillar formation (arrows). Notch inhibition resulted in a
very dense capillary plexus (same magnification) with a multitude of
pillars, demonstrated in the cast by tiny holes (arrows). b Vascular
cast from control mice at low and high magnification revealed normal
liver angioarchitecture. Notch down-regulation in the MxCre
Notch(lox/lox) mice induces formation of a dense capillary meshwork
due to the pronounced IA characterized by pillar formation (arrows)
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Fig. 6 Changes in expression levels of angiogenic (a) and chemo-
tactic factors (b) after inhibition of Notch, ephrinB2, and EphB4 in
the area vasculosa and in MxCre Notch(lox/lox) mice. Area
vasculosa: expression levels of VEGFA were slightly down-regulated
after Notch and EphB4 inhibition. VEGFR2 was most significantly
up-regulated after ephrinB2 (p \ 0.03, n = 6) and EphB4 blockade
(p \ 0.009, n = 6). Up-regulation of VEGFR1 in all treated samples
most remarkably after ephrinB2 (p \ 0.001, n = 6) and EphB4
(p \ 0.02, n = 6) inhibitions. The chemotactic factor SDF-1 and its
receptor CXCR4 were up-regulated (by 78 and 50 %, respectively)
after Notch inhibition, down-regulated after EphB4 inhibition and did
not show any change after ephrinB2 inhibition. In the Notch KO
mice, we detected an increase of 38 and 20 % in expression levels of
SDF-1 and CXCR4, respectively
Fig. 7 Injection of labeled bone marrow-derived mononuclear cells
(BMCs) in Notch-inhibited and PBS-treated samples of chicken area
vasculosa 24 h after treatment. Accumulation and extravasation of
BMCs (red) was much higher in GSI samples (b) compared to
controls (a), c represents higher magnification of b
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that BMCs participate in pillar formation after Notch
inhibition, a concept which is considerable progress in
understanding of intussusceptive angiogenesis.
A number of Notch-related pathways that play a pivotal
role in vascular development have been identified so far
[47–49]. Some of these, i.e., ephrinB2/EphB4, which are
responsible for the organization of cytoskeleton and cell
junctions, are good candidates for vessel stability. We
investigated vascular morphogenesis in our model upon
blocking of both forward and reverse ephrinB2/EphB4,
taking into account the complexity and distinct effects of
this bidirectional signaling. Our study showed that both
inhibitions disturb pericyte adherence to endothelial cells, a
fact reported previously [50, 51]. However, with the eph-
rinB2/EphB4 inhibition, no stimulation of intussusceptive
angiogenesis was observed, contrary to Notch inhibition. In
ephrinB2/EphB4 inhibited samples, the extent of vessel
leakage was lesser than in GSI-treated samples as well.
One of the primary modulators of the reciprocal commu-
nication between endothelial cells and pericytes is Angio-
poietin-1/Tie-2 signaling pathway [20]. Ang-1 and Tie-2-
null mice show reduced coverage and detachment of
pericytes, leading to destabilized, leakage-susceptible
vasculature [52, 53]. A positive regulation for Ang-1/Tie-2
pathway by Notch signaling was described recently [54]. In
the current study, we found that only Notch inhibition, but
Fig. 8 Injection of BMCs in the area vasculosa after Notch inhibition
(application site indicated by asterisk) dramatically induces increase
in microvascular density by onset of IA (arrows, b is higher
magnification of a). The area surrounding the application site
represented normal vascular pattern similar to the one observed in
the controls. c Microvascular area density increases significantly by
80 % after injection of BMCs in Notch-inhibited samples in
comparison with injection of BMCs in PBS (p \ 0.01, n = 6). Pillar
density demonstrated dramatic augmentation by 63 % compared to
the Notch inhibition alone and more than 400 % as compared to PBS
(p \ 0.001, n = 6)
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not ephrinB2 or EphB4 inhibition, down-regulated Tie-2.
This provides a possible mechanistic explanation for the
defects of endothelial/pericytes contacts and increased
vessel leakage observed after Notch inhibition.
Notch inhibition results in alteration of VEGF receptor
status. Recently, it has been shown that VEGFR1 and
VEGFR2 reciprocally determine tip cell selection. For the
initiation of the sprouting process, the cell needs lower
VEGFR1 and higher VEGFR2 levels, where the latter is
involved in negative feedback with Notch [4]. It is plau-
sible to expect that with increase in the ratio VEGFR2/
VEGFR1, there will be enhanced sprouting. Here, we
demonstrated that with high increase in VEGFR1 and
moderate elevation of VEGFR2 (increased ratio VEGFR1/
VEGFR2) in the context of Notch inhibition, intussuscep-
tion was the preponderant angiogenic mode.
It is becoming increasingly clear that intussusception is
synchronized by several cytokines. Recent studies have
demonstrated that bone marrow-derived endothelial pro-
genitor cells (EPCs) home at the sites of neovascularization
in response to tissue-derived or circulating cytokines. One
of the key chemokine players in developmental vasculari-
zation is the stromal cell-derived factor SDF-1, which by
binding to its receptor CXCR4 directs migration of pro-
genitor cells into the appropriate sites.
Stroma-derived factor-1-positive endothelium was
found lining the newly formed intraluminal vessels in
lobular capillary hemangiomas [55], possibly these were
sites of pillar formation. The SDF-1/CXCR4 signaling was
found to be regulated in endothelial cells through the Notch
ligand DLL4 [56]. Wrag et al. [57] demonstrated that
transplantation of rat bone marrow-derived progenitor
cells, positive for VEGFR1 and CXCR4, in ischemic hind
limbs increased capillary density by a SDF-1-dependent
manner, but did not differentiate into vascular structures
like endothelial cells or SMCs. The latter authors demon-
strated recruitment of progenitor cells to the adventitial–
medial border zone of the vessels. It has been observed by
others that recruitment of monocytes to ischemic tissues
can occur without incorporation or differentiation into
vascular lineages, suggesting their important role in neo-
vascularization by some alternative mechanism of angio-
genesis [58, 59]. In the present study, we observed up-
regulation of SDF-1 and CXCR4 after Notch inhibition and
down-regulation after EphB4 inhibition, up-regulation
being in association with intussusceptive angiogenesis. We
suggest that stimulation of intussusception after Notch
inhibition could be associated with elevated CXCR4/SDF-
1 expression. The latter factors are most probably essential
for the recruitment of mononuclear cells, participating in
the formation of pillars.
In conclusion, the recently published data indicated that
in the fronts of vessel invasion, inhibition of Notch results
in extensive formation of capillary sprouts. Our results
demonstrated that the same Notch inhibition within already
existing vascular beds (behind the sprouting fronts)
induced intussusceptive angiogenesis. The latter is associ-
ated with extravasation of mononuclear cells plausibly of
bone marrow origin, which participate in formation of the
intraluminal endothelial pillars. The vascular pattern
observed indicated that intussusceptive angiogenesis is
most likely ‘‘locked’’ in the ‘‘on’’ position after Notch
inhibition resulting in repetitive pillar formation. The
induced intussusception is complementary to excessive
sprouting at the front of vessel invasion and both types of
angiogenesis contributed to formation of a dense and
primitive vascular plexus without concomitant vascular
remodeling or maturation. The effect of Notch inhibition-
induced intussusceptive angiogenesis is not mediated by
ephrinB2/EphB4 signaling, but rather by chemokine sig-
naling. The results obtained in the current study have
potential implications on future treatment strategies of
angiogenesis related diseases such as carcinogenesis, reti-
nopathy and macular degeneration, among others.
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